24 febrero 2015
A new small molecule drug has been discovered that may serve as a treatment against multi-drug resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies. While standard anti-tuberculosis drugs can cure most people of Mycobacterium tuberculosis infection, improper use of antibiotics has led to new strains of the bacterium resistant to the two most powerful medications, isoniazid and rifampicin.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/PsRfHbPeNrg/150224172131.htm
